Display options
Share it on

Indian J Dermatol. 2018 Jan-Feb;63(1):18-21. doi: 10.4103/ijd.IJD_579_17.

Causality or Relatedness Assessment in Adverse Drug Reaction and Its Relevance in Dermatology.

Indian journal of dermatology

Sushil Pande

Affiliations

  1. Department of Dermatology, NKP Salve Institute of Medical Sciences and Lata Mangeshkar Hospital, Nagpur, Maharashtra, India.

PMID: 29527021 PMCID: PMC5838749 DOI: 10.4103/ijd.IJD_579_17

Abstract

Causality assessment essentially means finding a causal association or relationship between a drug and drug reaction. Identifying the culprit drug or drugs can be lifesaving or helpful in preventing the further damage caused by the drug to our body systems. In dermatology practice, when it comes to cutaneous adverse drug reaction, this is much more important and relevant because many aetiologies can produce a similar cutaneous manifestation. There are multiple criteria or algorithms available as of now for establishing a causal relationship in cases of adverse drug reaction (ADR), indicating that none of them is specific or complete. Most of these causality assessment tools (CATs) use four cardinal principles of diagnosis of ADR such as temporal relationship of drug with the drug reaction, biological plausibility of the drug causing a reaction, dechallenge, and rechallenge. The present study reviews some of the established or commonly used CATs and its implications or relevance to dermatology in clinical practice.

Keywords: Causality assessment; causality assessment tool; cutaneous adverse drug reaction

Conflict of interest statement

There are no conflicts of interest. What is new? While dermatologists have been doing causality assessment based on their individual knowledge and wisdom, the current article has reviewed some of the

References

  1. J Clin Pharmacol. 1994 Feb;34(2):142-7 - PubMed
  2. Drug Saf. 2008;31(1):21-37 - PubMed
  3. Clin Pharmacol Ther. 1977 Mar;21(3):247-54 - PubMed
  4. Clin Pharmacol Ther. 1981 Aug;30(2):239-45 - PubMed
  5. JAMA. 1979 Aug 17;242(7):623-32 - PubMed
  6. Fam Community Health. 1982 Aug;5(2):58-67 - PubMed
  7. Drug Inf J. 1984;18(3-4):271-3 - PubMed
  8. Therapie. 1985 Mar-Apr;40(2):111-8 - PubMed

Publication Types